UMMC Navigation

Lung/Respiratory Conditions

Main Content

RIN-PH-201

Study title

Multicenter, randomized, double blind, placebo-controlled trial to evaluate the safety and efficacy of inhaled treprostinil in subjects with pulmonary hypertension due to parenchymal lung disease

  • Principal Investigator: Dr. John Spurzem

Purpose

This study is evaluating the effect of an experimental drug in patients with pulmonary hypertension due to parenchymal lung disease.

Who can participate  

Those eligible to participate in this study include:

  • Males and females ages 18 or older with pulmonary hypertension and parenchymal lung disease

For more information

  • Cathy Hudgins
    University of Mississippi Medical Center
    2500 N. State St.
    Jackson MS 39216
    (601) 815-9276
  • IRB Number: 2017-0167